Author:
Ramanathan Ramesh K.,Lee Kenneth M.,McKolanis John,Hitbold Elizabeth,Schraut Wolfgang,Moser Arthur J.,Warnick Elizabeth,Whiteside Theresa,Osborne Jennifer,Kim Hyoung,Day Roger,Troetschel Monica,Finn Olivera J.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference22 articles.
1. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A 86:7159–7163
2. Barratt-Boyes SM, Vlad A, Finn OJ (1999) Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses. Clin Cancer Res 5:1918–1924
3. Doherty JF, Pinder M, Tornieporth N, Carton C, Vigneron L, Milligan P, Ballou WR, Holland CA, Kester KE, Voss G, Momin P, Greenwood BM, McAdam KP, Cohen J (1999) A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS, S/SBAS2 in semi-immune adults in The Gambia. Am J Trop Med Hyg 61:865–878
4. Edwards D, Berry JJ (1987) The efficiency of simulation-based multiple comparisons. Biometrics 43:913–928
5. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61–89